Goldman Sachs Group Inc Collegium Pharmaceutical, Inc Transaction History

Goldman Sachs Group Inc

  • $605 Billion
  • Q3 2024

A detailed history of Goldman Sachs Group Inc transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Goldman Sachs Group Inc holds 575,239 shares of COLL stock, worth $18 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
575,239
Previous 345,524 66.48%
Holding current value
$18 Million
Previous $11.1 Million 99.79%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$31.4 - $39.07 $7.21 Million - $8.97 Million
229,715 Added 66.48%
575,239 $22.2 Million
Q2 2024

Aug 13, 2024
BUY
$31.36 - $39.99 $5.69 Million - $7.26 Million
181,574 Added 110.75%
345,524 $11.1 Million
Q1 2024

May 15, 2024
SELL
$31.23 - $40.91 $1.28 Million - $1.68 Million
-41,112 Reduced 20.05%
163,950 $6.36 Million
Q4 2023

Feb 13, 2024
SELL
$21.16 - $30.8 $83,370 - $121,352
-3,940 Reduced 1.89%
205,062 $6.31 Million
Q3 2023

May 14, 2024
BUY
$21.23 - $24.28 $83,646 - $95,663
3,940 Added 1.92%
209,002 $4.67 Million
Q3 2023

Nov 14, 2023
SELL
$21.23 - $24.28 $80,992 - $92,628
-3,815 Reduced 1.79%
209,002 $4.67 Million
Q2 2023

May 14, 2024
BUY
$21.06 - $24.0 $2.02 Million - $2.3 Million
95,786 Added 81.85%
212,817 $4.57 Million
Q2 2023

Aug 14, 2023
BUY
$21.06 - $24.0 $2.02 Million - $2.3 Million
95,786 Added 81.85%
212,817 $4.57 Million
Q1 2023

May 14, 2024
BUY
$23.0 - $29.88 $663,389 - $861,828
28,843 Added 32.71%
117,031 $2.81 Million
Q1 2023

May 11, 2023
BUY
$23.0 - $29.88 $663,389 - $861,828
28,843 Added 32.71%
117,031 $2.81 Million
Q4 2022

May 14, 2024
SELL
$16.14 - $23.55 $240,824 - $351,389
-14,921 Reduced 14.47%
88,188 $2.05 Million
Q4 2022

Feb 13, 2023
SELL
$16.14 - $23.55 $240,824 - $351,389
-14,921 Reduced 14.47%
88,188 $2.05 Million
Q3 2022

May 14, 2024
BUY
$15.46 - $20.1 $649,134 - $843,958
41,988 Added 68.7%
103,109 $1.65 Million
Q3 2022

Nov 10, 2022
BUY
$15.46 - $20.1 $649,134 - $843,958
41,988 Added 68.7%
103,109 $1.65 Million
Q2 2022

May 14, 2024
SELL
$14.22 - $20.88 $2.05 Million - $3.01 Million
-143,941 Reduced 70.19%
61,121 $1.08 Million
Q2 2022

Aug 15, 2022
SELL
$14.22 - $20.88 $564,278 - $828,560
-39,682 Reduced 39.37%
61,121 $1.08 Million
Q1 2022

May 16, 2022
SELL
$17.2 - $22.5 $813,852 - $1.06 Million
-47,317 Reduced 31.95%
100,803 $2.05 Million
Q4 2021

Feb 14, 2022
SELL
$17.5 - $21.35 $644,875 - $786,747
-36,850 Reduced 19.92%
148,120 $2.77 Million
Q3 2021

Nov 10, 2021
BUY
$17.75 - $25.39 $3.28 Million - $4.7 Million
184,970 New
184,970 $3.65 Million

Others Institutions Holding COLL

# of Institutions
256
Shares Held
38.6M
Call Options Held
100K
Put Options Held
21.1K
View Full List

About COLLEGIUM PHARMACEUTICAL, INC

COLL Quotes by TradingView
  • Ticker COLL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 34,126,200
  • Market Cap $1.07B
  • Description
  • Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...
More about COLL
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email